The Discounted Cash Flow (DCF) valuation of Parenteral Drugs (India) Ltd (PDPL.NS) is 42.80 INR. With the latest stock price at 2.90 INR, the upside of Parenteral Drugs (India) Ltd based on DCF is 1375.7%.
Based on the latest price of 2.90 INR and our DCF valuation, Parenteral Drugs (India) Ltd (PDPL.NS) is a buy. buying PDPL.NS stocks now will result in a potential gain of 1375.7%.
| Range | Selected | |
| WACC / Discount Rate | 8.5% - 17.6% | 13.1% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 21.59 - 92.91 | 42.80 |
| Upside | 644.5% - 3103.7% | 1375.7% |